Peking University Third Hospital: Lung Neoplasms trials

The registry lists 12 Lung Neoplasms studies with Peking University Third Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 2Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• 68Ga-SorB PET/CT Imaging in Patients With Solid TumorsRecruitingNCT07760012Not applicable
• LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung CancerEnrolling by invitationNCT06876675
• Observation on the Frailty Status of Lung Cancer PatientsRecruitingNCT06448455
• Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung CancerNot yet recruitingNCT05802654Not applicable
• I-125 Seeds Implantation in the Treatment of Recurrent Lung Cancer After RadiotherapyRecruitingNCT04071418
• Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung CancerStatus unknownNCT05802641
• Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT05485350Phase 2
• Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions：A Preliminary Lung Centered StudyCompletedNCT04960631
• Ultralow-dose CT for Lung Cancer ScreeningCompletedNCT04957030Not applicable
• CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung CancerCompletedNCT03916367
• Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung CancerStatus unknownNCT03050411Phase 1
• Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.Status unknownNCT02350361Phase 2/3